JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
4651
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $104K | ﹤0.01% |
939
+27
| +3% | +$3.52K |
|
4652
DHI Group
DHX
$182M
| $103K | ﹤0.01% |
67,814
-23,190
| -25% | -$40.1K |
|
4653
StealthGas
GASS
$332M
| $103K | ﹤0.01% |
37,300
+10,867
| +41% | +$36.4K |
|
4654
Verrica Pharmaceuticals
VRCA
$89.7M
| $103K | ﹤0.01% |
1,260
+1,126
| +840% | +$137K |
|
|
FRTX
4655
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $103K | ﹤0.01% |
277
-164
| -37% | -$64.3K |
|
4656
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$221M
| $102K | ﹤0.01% |
4,242
| – | – |
|
4657
Global X SuperDividend REIT ETF
SRET
$233M
| $102K | ﹤0.01% |
+2,500
| New | +$109K |
|
4658
Alphatec Holdings
ATEC
$1.46B
| $101K | ﹤0.01% |
43,901
-4,992
| -10% | -$14.1K |
|
4659
VanEck Intermediate Muni ETF
ITM
$2.14B
| $101K | ﹤0.01% |
2,118
-1
| -0% | -$47 |
|
4660
Kura Oncology
KURA
$800M
| $101K | ﹤0.01% |
7,228
+675
| +10% | +$8.94K |
|
4661
Parke Bancorp
PKBK
$401M
| $101K | ﹤0.01% |
5,935
+335
| +6% | +$5.93K |
|
|
CIVI
4662
DELISTED
Civitas Resources
CIVI
| $100K | ﹤0.01% |
4,814
+448
| +10% | +$11.8K |
|
4663
Peoples Financial Services
PFIS
$704M
| $100K | ﹤0.01% |
2,253
+657
| +41% | +$27.9K |
|
|
ATRS
4664
DELISTED
Antares Pharma, Inc.
ATRS
| $100K | ﹤0.01% |
36,877
-904,240
| -96% | -$2.98M |
|
4665
Ducommun
DCO
$2.7B
| $99K | ﹤0.01% |
2,718
-11,256
| -81% | -$433K |
|
4666
Hackett Group
HCKT
$270M
| $99K | ﹤0.01% |
6,155
-7,811
| -56% | -$146K |
|
4667
Rigel Pharmaceuticals
RIGL
$681M
| $99K | ﹤0.01% |
4,289
-9,254
| -68% | -$261K |
|
|
BLMT
4668
DELISTED
BSB Bancorp, Inc.
BLMT
| $99K | ﹤0.01% |
3,540
+1,589
| +81% | +$47.3K |
|
4669
Brown-Forman Class A
BF.A
$13.4B
| $98K | ﹤0.01% |
2,067
+577
| +39% | +$27.5K |
|
4670
VanEck Pharmaceutical ETF
PPH
$959M
| $98K | ﹤0.01% |
1,787
-82
| -4% | -$4.97K |
|
|
VRAY
4671
DELISTED
ViewRay, Inc.
VRAY
| $98K | ﹤0.01% |
16,130
-548,164
| -97% | -$4.11M |
|
|
TYME
4672
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $98K | ﹤0.01% |
26,557
+16,827
| +173% | +$47.3K |
|
4673
Ceco Environmental
CECO
$3.85B
| $97K | ﹤0.01% |
14,436
+7,410
| +105% | +$56.7K |
|
4674
Chunghwa Telecom
CHT
$33.1B
| $97K | ﹤0.01% |
2,730
+36
| +1% | +$1.25K |
|
|
GLDD
4675
DELISTED
Great Lakes Dredge & Dock
GLDD
| $97K | ﹤0.01% |
14,579
-12,017
| -45% | -$78.4K |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.